9 -Tetrahydrocannabinol (THC), through its action on cannabinoid type-1 receptor (CB 1 R), is known to activate dopamine (DA) neurotransmission. Functional evidence of a direct antagonistic interaction between CB 1 R and DA D 2 -receptors (D 2 R) suggests that D 2 R may be an important target for the modulation of DA neurotransmission by THC. The current study evaluated, in rodents, the effects of chronic exposure to THC (1 mg/kg/day; 21 days) on D 2 R and D 3 R availabilities using the D 2 R-prefering antagonist and the D 3 R-preferring agonist radiotracers [ In caudate/putamen (CPu), THC exposure was associated with increased densities of D 2 R with no change in D 2 R mRNA expression, whereas in nucleus accumbens (NAcc) both D 3 R binding and mRNA levels were upregulated. These receptor changes, which were completely reversed in CPu but only partially reversed in NAcc and midbrain at 1 week after THC cessation, correlated with an increased functionality of D 2/3 R in vivo, based on findings of increased locomotor suppressive effect of a presynaptic dose and enhanced locomotor activation produced by a postsynaptic dose of quinpirole. Concomitantly, the observations of a decreased gene expression of tyrosine hydroxylase in midbrain together with a blunted psychomotor response to amphetamine concurred to indicate a diminished presynaptic DA function following THC. These findings indicate that the early period following THC treatment cessation is associated with altered presynaptic D 2/3 R controlling DA synthesis and release in midbrain, with the concurrent development of postsynaptic D 2/3 R supersensitivity in NAcc and CPu. Such D 2/3 R neuroadaptations may contribute to the reinforcing and habit-forming properties of THC.
INTRODUCTION
The main psychoactive constituent of cannabis, D 9 -tetrahydrocannabinol (THC), produces a wide range of psychoactive effects through activation of central cannabinoid type-1 receptors (CB 1 R). CB 1 R are widely expressed throughout the brain (Mailleux and Vanderhaeghen, 1992) , with a high expression in extended regions of the mesoaccumbens and nigrostriatal dopaminergic systems that are involved in reward, motivation, and locomotor processes. Although CB 1 R are found exclusively on glutamatergic and GABAergic axon terminals in midbrain (Matyas et al, 2006 (Matyas et al, , 2008 , they are localized both presynaptically, on GABAergic and glutamatergic terminals, and postsynaptically in somatodendritic profiles of medium spiny neurons in striatum (review in Fitzgerald et al, 2012) . This distribution provides multiple opportunities for functional interactions between the endocannabinoid and ascending dopamine (DA) pathways, and growing evidence indicate that CB 1 R signaling directly or indirectly modulates DA neurotransmission through either postsynaptic or presynaptic mechanisms (Laviolette and Grace, 2006) . It is well established that acute administration of THC activates the firing of DA neurons in the ventral tegmental area (VTA) and substantia nigra (SN; French et al, 1997) , and enhances DA release in their respective DA terminal field, the nucleus accumbens (NAcc; Tanda et al, 1997) and caudate-putamen (CPu; Taylor et al, 1988) . As with other drugs of abuse, it is believed that the reinforcing properties and abuse liability of THC are related to activation of the mesolimbic DA pathway (Lupica et al, 2004) . The mechanisms through which CB 1 R influence DA neurotransmission remain incompletely understood, but likely involve a transsynaptic modulation exerted by glutamatergic and GABAergic inputs onto mesoaccumbens and nigrostriatal DA neurons (review in Laviolette and Grace, 2006) . Accumulating evidence also indicate the existence of a direct cross talk and modulation of signaling upon heterodimerization between CB 1 R and the DA D 2 -receptor (D 2 R) subtype (Kearn et al, 2005) . Behavioral studies support a functional cross talk between the two receptor systems, as acute CB 1 R blockade potentiates the locomotor stimulant effect of D 2 R agonists (Giuffrida et al, 1999) , whereas acute CB 1 R stimulation inhibits it (Beltramo et al, 2000) . Further evidence indicating antagonistic CB 1 R/D 2 R interactions comes from data showing that acute CB 1 R stimulation reduces the affinity of D 2 R agonist binding in striatal membranes (Marcellino et al, 2008a) . Contrasting with an inhibitory influence of acute CB 1 R stimulation on D 2 R signaling, the opposite effect emerged following chronic CB 1 R stimulation; that is, a potentiation of D 2 R psychomotor function (Moreno et al, 2005) . Taken together, these data suggest that the DA D 2 R may be an important target for the modulation of DA function by cannabinoids and that this receptor may be involved in the cannabisreinforcing effects. To date though, the impact of chronic CB 1 R agonist treatment on D 2 R is poorly understood and the only few studies performed have given equivocal results (Dalton and Zavitsanou, 2010; Safont et al, 2011; Sevy et al, 2008) .
The present study examined the effects on D 2/3 R signaling of repeated exposure to low doses of THC that appear relevant to human recreational use of cannabis. D 2/3 R availabilities were evaluated in the rat brain using smallanimal positron emission tomography (PET) imaging and [ 18 F]fallypride, a D 2 R-preferring antagonist radiotracer for which selectivity is Circa 10-fold higher for D 2 R over D 3 R (Mukherjee et al, 1999) . To investigate the THC effects on D 3 R, we used ex-vivo autoradiography and the D 3 Rpreferring agonist radiotracer [ 3 H]-( + )-PHNO that possesses more than 50-fold higher selectivity for D 3 R over D 2 R (Freedman et al, 1994; Rabiner et al, 2009) . Thus, although both radiotracer bindings in D 2 R-rich regions such as the CPu reflect D 2 R availabilities, comparison of [
H]-( + )-PHNO and [
18 F]fallypride bindings in D 3 R-rich regions such as the midbrain and ventral pallidum (VP) allowed to study the differential effects of THC on D 3 R vs D 2 R (Rabiner et al, 2009 ). In addition, expression of the mRNAs encoding CB 1 R, D 2 R, D 3 R, and tyrosine hydroxylase (TH), the ratelimiting enzyme in DA biosynthesis, were measured to obtain information on whether changes induced by chronic THC dosing would be relatively selective for D 2 receptors, or whether it would also influence the expression of other genes important to DA neurotransmission. To further assess the function of pre-and postsynaptic DA signaling, we also investigated the effect of chronic THC on the locomotor stimulant effect of amphetamine and quinpirole. Our data show that, concomitant to a CB 1 R downregulation, chronic THC elicits a supersensitivity of D 2 R and D 3 R in vivo, and induces opposed alterations in the behavioral response to high doses of quinpirole and amphetamine.
MATERIALS AND METHODS

Animals and Treatments
Male Sprague-Dawley rats weighing 250-275 g were used. THC (Sigma-Aldrich) was dissolved in 0.9% saline/ethanol/ cremophor (18 : 1 : 1) and administered intraperitoneally (i.p.) at 1 mg/kg/day. Unless otherwise stated, treatment duration was 3 weeks and treatment effects were measured at 24 h after the last THC dose. The dose of THC was chosen based on previous studies, suggesting that at such a low dose, THC has positive reinforcing effects as it stimulates mesolimbic DA activity (Chen et al, 1990; Gessa et al, 1998) , enhances brain stimulation reward (Lepore et al, 1996) , and can also produce rewarding effects, when they do occur, in the place preference paradigm, whereas higher doses often result in conditioned place aversion (Ghozland et al, 2002; Valjent and Maldonado, 2000 ; but see also Le Foll et al, 2006) .
Quinpirole hydrochloride (Tocris Biosciences) and D-amphetamine (AMPH; Sigma-Aldrich) were administered i.p. at 0.05 or 0.5 and at 2.5 mg/kg, respectively.
Positron Emission Tomography Imaging
Image acquisition. for 120 min. The average specific radioactivity at the time of injection was 166 GBq/mmol (range: 63-257 GBq/mmol). Sinograms were reconstructed using the expectation maximization algorithm with 20 iterations, which yields an image resolution of 1.9 mm full-width-at-half-maximum (Motta et al, 2002) .
Immediately after completion of the PET acquisition, animals were killed by decapitation, and their brain immediately processed for ex-vivo autoradiography as described below.
Image analysis. PET images were processed using the software PMOD V3.2 (PMOD Technologies, Switzerland). Summation PET images were generated over the 10-120-min of dynamic data and manually coregistered to a magnetic resonance imaging (MRI) atlas of the rat brain (Schweinhardt et al, 2003) . The resulting transformation was applied to the PET dynamic images, mapping all rat brains into the same reference space.
A region of interest (ROI) template was defined on the MRI atlas, using the rat brain atlas of Paxinos and Watson (1998) and previous guidelines described for analyzing rodent PET data (Dalley et al, 2007) . The ROI template included four brain regions: the dorsolateral striatum (DST; wherein CPu is located), the ventral striatum (VST; wherein NAcc is located), the cerebellar cortex, and a ventral midbrain region including both SN and VTA (SN/VTA). ROIs consisted of fixed-size circular ROIs placed bilaterally Effect of chronic THC on D 2/3 R N Ginovart et al over the DST and VST (2 mm in diameter), and SN/VTA (1.4 mm in diameter). To minimize partial voluming, ROIs were placed on the central planes on which the structures appeared. A single elliptical ROI (2 mm Â 1 mm) was placed on cerebellar cortex, primarily over the central lobule in order to reduce spill-over from bone uptake of [ 18 F]fluoride. The ROI template was applied to the dynamic images to produce time-activity curves for the target-rich (DST) and reference region (cerebellar cortex), which were then used to generate parametric maps. Voxel-wise parametric maps of the binding potential (BP ND ) were calculated using the Logan graphical method (Logan et al, 1996) Brains were cut into series of two adjacent sections (30 mm thick), taken at 150 mm interval along the caudorostral extension of the CPu, NAcc, VP, SN, and VTA. The first section was stained for acetylcholinesterase as previously described (Karnovsky and Roots, 1964) F-radioactive scale in all ROIs examined. Ex-vivo binding of both radioligands in target ROIs was quantified using the specific binding ratio (SBR), which is defined as SBR ¼ (ROIÀcerebellum)/cerebellum, and where cerebellar cortex is used as reference to estimate free and nonspecifically bound radiotracer.
Quantitative mRNA Estimation by Real-Time RT-PCR Rats were treated for 3 weeks with THC or vehicle and killed by decapitation at 24 h after the last treatment dose, and their brain was cut serially into 300 mm-thick coronal sections. Tissue samples of the CPu, NAcc, VP, SN/VTA, and cortex were removed bilaterally from all sections they were visible on using a 1.5-mm-diameter stainless-steel puncher. SN and VTA were collected together as the two structures were not easily distinguishable on fresh tissue sections. Tissue punches and tissue remaining in sections, which was to be used as calibrator, were preserved at À801C.
Total RNA was isolated from tissue punches with Accuzol (Labgene Scientific) and treated with Turbo DNAse (Ambion). RNA quality and yield were assessed by spectrophotometry. Reverse-transcriptions were performed with total RNA (1 mg) using a cDNA synthesis kit (Bioline) with random hexamer (130 ng) and oligos dT (25 ng). RT-PCR reactions were carried out in duplicate on RotorGene (Corbett, Qiagen) according to the Kapa SYBR green protocol (Labgene Scientific). Thermal cycler conditions were 3 min at 951C followed by 45 cycles of 5 s at 951C, 20 s at 601C, and 2 s at 721C. Primers were evaluated using linear regression analysis. Primer characteristics are given in Table 1 . Samples were quantified using the DDC T method with efficiency correction (Pfaffl, 2001) , using the calibrator tissue and glyceraldehyde-3-phosphate dehydrogenase and hypoxanthine-guanine phosphoribosyltransferase as references genes for normalization.
Effect of THC Exposure on the Locomotor Response to Amphetamine and Quinpirole
Motor activity was measured using the ActiMot System (TSE System) that contained four infrared-beam-operated open fields (48 Â 48 Â 40 cm). Each open field contained three sets of 16 beams: two sets in the x-y axis to measure horizontal activity and one set in the z-axis to monitor rears.
To determine the longitudinal effect of THC on locomotion, rats were tested at baseline (day 0) and at sequential times throughout the course of chronic THC or vehicle. For baseline data (day 0), animals were given an i.p. injection of saline and placed, 30 min later, into the open field for 60 min. The following day (day 1), rats received their first injection of THC or vehicle and returned to the open field 30 min later for 60 min. The same procedure was repeated on days 7, 14, and 21. Horizontal locomotor activity, expressed as distance travelled (in meters), was calculated either in 5 min blocks or for the entire 60-min testing period.
To determine the effect of THC on the psychomotor response to AMPH, the same animals were tested on days 20 and 22. On day 20, before their 20th treatment injection, animals were placed in the open field for 45 min of habituation. Rats then received a saline injection as a mild stressor and were monitored for an additional 90 min. On day 22 (24 h after the last THC dose), rats were allowed to habituate in the open field for 45 min before AMPH (2.5 mg/kg; i.p.), followed by an additional 90-min testing in the open field.
Two other cohorts of animals were used to determine the effect of chronic THC on the locomotor response to either a postsynaptic (0.5 mg/kg; Eilam and Szechtman, 1989) or a presynaptic (0.05 mg/kg; Eilam and Szechtman, 1989) dose of quinpirole. On day 22, rats in the first cohort were allowed to habituate in the open field for 45 min before quinpirole (0.5 mg/kg; i.p.), followed by an additional 90-min testing in the open field. Rats in the second cohort were tested on day 20 (before their 20th treatment injection) and on day 22 (24 h after the last THC dose). Animals were i.p. injected with saline and with 0.05 mg/kg quinpirole on days 20 and 22, respectively, and immediately placed in the open field for 120 min.
Horizontal locomotor activity was calculated either in 5 or 15 min blocks, or for the entire postinjection time period. Furthermore, the number of rears, the time spent in the center, and at the periphery of the open field were also measured.
To analyze the time-course effect of saline, AMPH, and quinpirole, locomotor activity data were expressed as the percentage of the 15-min epoch pre-injection value.
Statistical Analysis
Between-group differences in BP ND , SBRs, and mRNA levels were analyzed with a mixed model repeated measures analysis of variance, with the region as the repeated measure and treatment as the between-subject factor. When significant differences were detected, post hoc comparisons were performed using unpaired two-tailed Student's t-tests. Behavioral data were analyzed using a two-way ANOVA (treatment Â time) with a LSD post hoc test. Significance was defined as po0.05.
RESULTS
Chronic THC Increases Postsynaptic D 2/3 R Binding
Mean parametric maps of [ (Figure 2b) .
In subsequent studies, we aimed to determine whether these changes in [ 3 H]-( + )-PHNO binding observed at 24 h after cessation of a 3-weeks treatment with THC were readily measurable with a shorter duration of drug exposure and with a longer period of drug discontinuation. To this end, rats were treated with THC or its vehicle for either 1 or 3 weeks, and ex vivo [ The use of quantitative real-time PCR gave reliable estimates of CB 1 R, D 2 R, D 3 R, and TH mRNA levels within the six different regions examined, and the relative abundance of each mRNA transcript in vehicle-and THCtreated animals is shown in Figure 4 .
In control vehicle animals, the anatomical brain distribution of CB 1 R mRNA (Figure 4a ) was consistent with and extended previous in situ hybridization studies. Highest expression of CB 1 R mRNA was found in CPu followed by the neocortex, whereas moderate expression was detected in VP. Contrasting with previous in situ hybridization studies (Berrendero et al, 1999; Mailleux and Vanderhaeghen, 1992) , low but clearly detectable levels of CB 1 R mRNA were found in NAcc and in SN/VTA, a finding most likely reflecting the higher sensitivity of RT-PCR compared to in situ hybridization. The highest concentrations of D 2 R mRNA were found in the CPu, where its concentration was twofold higher than that in the NAcc. D 2 R mRNA was least abundant in VP, with intermediate levels of expression in the SN/VTA (Figure 4b) . In contrast to the D 2 R gene, the expression of the D 3 R gene was most and approximately equally abundant in NAcc, and VP where its expression was B30-50-fold higher than that in the CPu and SN/VTA Effect of chronic THC on D 2/3 R N Ginovart et al (Figure 4c ). Low levels of D 2 R and D 3 R mRNAs were detected in neocortex. Levels of TH mRNA in SN/VTA DAcontaining cell bodies were B400-fold higher than in the DA terminal fields of the CPu and NAcc (Figure 4d ).
Although there was no main effect of treatment on CB 1 R mRNA levels (F (1,76) ¼ 2.39, p40.05), there was a highly significant effect of region (F (4,76) ¼ 62.44, po0.001) and a significant treatment-by-region interaction (F (4,76) ¼ 4.77, po0.002). Chronic THC treatment induced significant decreases in CB 1 R gene expression in both CPu (À33%, po0.05; Figure 4a ) and SN/VTA (À25%, po0.05; Figure 4a ) when compared with vehicle treatment. No THC effect was found in any other regions examined. Chronic THC treatment did not induce significant alteration in D 2 R gene expression (treatment: F (1,76) ¼ 0.13, p40.05; treatment Â region: F (4,76) ¼ 0.54, p40.05; Figure 4b ) but did induce a significant increase in D 3 R gene expression (treatment: F (1,72) ¼ 6.44, p ¼ 0.02; treatment Â region: F (4,72) ¼ 3.57, p ¼ 0.01; Figure 4c ). D 3 R mRNA levels were increased in the NAcc ( + 36%; po0.05) without significant change in any other region (Figure 4c ). Importantly, there was a main effect of treatment on TH gene expression (treatment: F (1,38) ¼ 4.52, po0.05; treatment Â region: F (2,38) ¼ 4.54, po0.02; Figure 4d ). TH mRNA levels were significantly decreased (À25%; po0.05) by THC treatment in SN/VTA (Figure 4d ). Data are shown as mean ± SEM (n ¼ 4) in the caudate/putamen (CPu), nucleus accumbens (NAcc), ventral pallidum (VP), substantia nigra (SN), and ventral tegmental area (VTA). Significantly different from the vehicletreated group at *po0.05 and **po0.01 using a mixed model repeatedmeasures ANOVA with a post hoc t-test. 
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Chronic THC Induces Functional Tolerance Figure 5 shows the time-course of alterations in THC-induced locomotor activity on days 1, 7, 14, and 21 of treatment as measured 30 min after injection. Twoway repeated ANOVA analysis showed that the effect of THC on locomotion was dependent on the day of testing (F (4,672) ¼ 2.84, po0.05). When compared with vehicle treatment, THC significantly reduced (À32%; po0.015) locomotor activity at 1 day but not at 7, 14, or 21 days of treatment. By the 7th injection, the acute depressive effect of THC on locomotor activity was thus no longer apparent, a result indicative of functional tolerance and consistent with a desensitization of CB 1 R.
Locomotor Activity Response to Amphetamine and Quinpirole Challenges
Spontaneous locomotor activity measured after a challenge dose of saline in rats treated chronically with THC was not different from that of vehicle-treated animals ( Figure 6a ). Administration of AMPH (2.5 mg/kg i.p.) produced a marked and sustained rise in locomotor activity, which reached maximal levels at 15 min postinjection and remained elevated above baseline levels over the 90-min of monitoring (Figure 6a ). When compared with control animals, THC-treated rats exhibited a lower, time-dependent locomotor response to AMPH (treatment: Figure 4 Relative mRNA levels for CB 1 R (a), D 2 R (b), D 3 R (c), and tyrosine hydroxylase (d) in caudate/putamen (CPu), nucleus accumbens (NAcc), ventral pallidum (VP), substantia nigra (SN), ventral tegmental area (VTA), and cortex of rats as measured at 24 h following cessation of a 3-weeks treatment with either vehicle or THC. Levels of mRNA were measured by RT-qPCR, quantitated using the DDC T method, and the results evaluated as the relative ratio of the expression level of each mRNA to that of both glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and hypoxanthine-guanine phosphoribosyltransferase (HPRT). Data are presented as mean ± SEM (n ¼ 15). Significantly different from the vehicle-treated group at *po0.05 using a mixed model repeated-measures ANOVA followed, when appropriate, by a post hoc t-test. Shown on the upper panel are schematic coronal sections adapted from a rat brain atlas (Paxinos and Watson, 1998) displaying the positions of the 1.5-mm-diameter circular tissue punches used for mRNA extraction.
Effect of chronic THC on D 2/3 R N Ginovart et al po0.01; Figure 6a ). When data were binned over the 90-min postinjection time period (Figure 6c ), THC treatment decreased the horizontal and vertical (rearings) locomotor response to AMPH by B15% (po0.01; Figure 6c ) and 23% (po0.05; Figure 6e ), respectively. AMPH did not affect the time spent by any animals at the periphery of the open field ( Figure 6i ) but significantly increased the time spent at the center in both the VEH-and THC-treated animals, with no difference between the two groups ( Figure 6g ). Rats treated with THC exhibited a marked increased response to a postsynaptic dose (0.5 mg/kg; Eilam and Szechtman, 1989) Figure 6b ). When data were binned over the 90-min postinjection time period, the horizontal and vertical (rearings) locomotor responses to a postsynaptic dose of quinpirole were Btwofold higher in THC-treated than in vehicle-treated animals (Figure 6d and f; po0.001). As AMPH, quinpirole significantly increased the time spent at the center of the open field in both VEH-and THC-treated animals (Figure 6h ), but this effect was significantly more pronounced in THC-treated animals. No effect of quinpirole was observed on the time spent at the periphery of the area (Figure 6j ).
When compared with saline, administration of a low, presynaptic, dose of quinpirole (0.05 mg/kg; Eilam and Szechtman, 1989 ) produced a marked decrease in locomotor activity in both VEH-(treatment: F (1,336) ¼ 69.20, po0.001; treatment Â time: F (23,336) ¼ 2.12, po0.01; Figure 7a ) and THC-treated animals (treatment: Locomotor activity (m) Figure 5 Longitudinal effect of a chronic treatment with THC (1 mg/kg/ day; 21 days) or its vehicle on locomotor activity. Locomotor activity was measured as the distance travelled in meters and monitored at 30 min postinjection of THC or vehicle for 60 min. Measurements were done at baseline conditions (day 0) and after the 1st (day 1), 7th (day 7), 14th (day 14), and last (day 21) injection of THC or VEH. Data are presented as mean±SEM (n ¼ 8). Significantly different from the vehicle-treated group at *po0.05, using a two-way ANOVA followed by a LSD post hoc test. Significantly different from the respective VEH-treated group at *po0.05, **po0.01, and ***po0.001, and significantly different from the respective saline-treated group at + po0.05 and + + po0.01, using a two-way ANOVA followed by a LSD post hoc test. Figure 7a and b) and numbers of rears (treatment: F (1,336) ¼ 5.21, po0.02; treatment Â time: F (23,336) ¼ 1.07, p40.05; data not shown). When data were binned over the 120-min of testing and compared with the respective saline-treated control data, a 0.05-mg/kg challenge dose of quinpirole caused significantly higher reductions of both horizontal (po0.01) and vertical (po0.02) locomotor activity in THC-treated (À67.9% and À63.5%, respectively; Figure 7c ) than in vehicle-treated animals (À51.7% and À50.6%, respectively; Figure 7d ). A low dose of quinpirole had no effect on the time spent at the center (Figure 7e ) or at the periphery of the open field (Figure 7f ).
DISCUSSION
To our knowledge, this is the first study to investigate the effects of THC on D 2 R and D 3 R. Our results indicate that a 3-weeks treatment with relatively low doses of THC has a pervasive effect on D 2 R and D 3 R in the nigrostriatal and mesolimbic DA pathways. When measured at 24 h after THC treatment cessation, both D 2 R and D 3 R were upregulated in the SN and VTA, indicating a supersensitivity of the midbrain D 2/3 R that was associated with a concurrent decrease in TH gene expression. THC exposure also increased D 2 R availability in CPu and upregulated D 3 R in NAcc. These receptor changes correlated with an increased functionality of pre-and postsynaptic D 2/3 R in vivo, as indicated by findings of increased locomotor suppressive effects of a low, presynaptic dose of quinpirole and enhanced locomotor activation produced by a higher, postsynaptic dose of quinpirole. Concomitantly, the psychomotor response to the presynaptic DA releaser AMPH was diminished following THC. Our results support the notion of a hypodopaminergic state resulting from altered presynaptic mechanisms controlling DA synthesis and release during the early period after THC cessation, with the concurrent development of postsynaptic DA receptor supersensitivity.
The results of the present study moreover demonstrate that dysregulations of D 2 R and D 3 R receptors occur rapidly following THC exposure (ie, within the first week) and that these dysregulations persist during the initial phase of abstinence (7 days) of a 3-weeks THC exposure. Furthermore, our data also indicate that recovery of D 2 R and D 3 R densities during abstinence exhibits regional brain differences, with D 2 R in CPu showing more rapid recovery than D 3 R in NAcc and midbrain. These data suggest that chronic THC exposure may not produce permanent alterations in the DA D 2 -like receptor system, but that recovery within the mesolimbic system may require prolonged abstinence from drug use. Owing to its high lipophilicity and sequestration in fat, the tissue half-life of THC is long (B5 days; Kreuz and Axelrod, 1973) and the drug likely persists at brain CB 1 R for days after discontinuing treatment. This makes difficult to distinguish whether THC effects on D 2/3 R arise from indirect effects of residual drug or from the effects of drug withdrawal.
In addition to increased D 2/3 R binding in midbrain, further evidence for a THC-induced sensitization of midbrain DA autoreceptors was obtained based on findings of a heightened locomotor suppressive effect of low dose of quinpirole, an effect that has been attributed to presynaptic activation of D 2/3 autoreceptors (Aghajanian and Bunney, 1977; White and Wang, 1984) . Midbrain D 2/3 autoreceptors inhibit DA cell firing, thereby decreasing DA release in terminal fields (Westerink et al, 1996) . The development of supersensitive midbrain DA autoreceptors following chronic THC is thus expected to result in increased selfinhibition and hypoactivity of DA neurons. This hypothesis concurs with the substantial decrement in spontaneous electrical activity of NAcc-projecting DA neurons observed in VTA following repeated THC and with the abrupt reductions in mesolimbic DA neuronal activity and accumbal DA levels following SR 141716A-precipitated THC withdrawal Tanda et al, 1999) . Significantly different from the respective VEH-treated group at *po0.05 and **po0.01, and significantly different from the respective saline-treated group at + po0.05, + + po0.01, and + + + po0.001 using a two-way ANOVA followed by a LSD post hoc test.
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Further evidence for a diminished presynaptic DA function is the decreased gene expression of TH in SN/VTA, a finding that ties up with the reduced TH activity reported in striatum following repeated CB 1 R stimulation (Moranta et al, 2009) . Such effects are expected to diminish the maximal capacity of midbrain neurons to synthesize and release DA and likely underlie the diminished locomotor response to AMPH observed in THC-treated animals. A THC-induced presynaptic DA hypofunction is consistent with the reduced release of accumbal DA observed in response to alcohol and morphine in rats chronically preexposed to cannabinoid agonists (Cadoni et al, 2008; LopezMoreno et al, 2008) . Such an attenuated response of mesolimbic DA release to drug challenge has also been observed during the early phase of withdrawal (ie, within the first week) of chronic exposure to several psychostimulants and opiates (Rossetti et al, 1992; Spanagel et al, 1994) . Taken together, the decreased expression of TH and supersensitive D 2/3 R observed in midbrain combined with the blunted locomotor response to AMPH suggests that, as observed with other drugs of abuse, chronic THC exposure causes a presynaptic mesolimbic DA hypofunction during the early period following THC cessation.
To date, few studies have investigated the effects of chronic cannabinoid exposure on D 2/3 R in striatum. Using [ 11 C]raclopride, two independent studies (Sevy et al, 2008; Stokes et al, 2012) found normal levels of striatal D 2/3 R in detoxified cannabis users. However, given the length of cannabis abstinence (412 weeks in Sevy et al (2008) ; 18 months on average in Stokes et al (2012) ), abnormal D 2/3 R density may have had recovered at time of measurement. After shorter periods of cannabinoid abstinence (ie, 24 h), higher striatal D 2 R binding have been reported in cannabis users with first-episode psychosis than in nonusers and in healthy controls, although the difference was not significant due to insufficient statistical power (Safont et al, 2011) . Lastly, using [ 3 H]raclopride in rats chronically exposed to the synthetic CB 1 R agonist HU-210, Dalton and Zavitsanou (2010) found an overall increase in D 2 R across all cerebral regions examined (which included CPu and NAcc) relative to controls, although region-by-region comparisons failed to reach significance in any individual brain area. In light of these studies, it thus remained unclear whether any change in striatal D 2/3 R density, even subtle, occurs following chronic cannabinoid exposure. Here, we provided evidence that postsynaptic DA receptor supersensitization mechanisms involving an increased density and enhanced agonist recognition of D 2/3 R developed in striatum over the course of THC treatment. In NAcc, which contains similar amount of D 2 R and D 3 R, chronic THC produced an increase in [ However, concurrent behavioral data indicated that the locomotor activation produced by a 0.5-mg/kg dose of quinpirole was dramatically enhanced following THC. Although quinpirole has high affinity for both D 2 R and D 3 R (Freedman et al, 1994) , the drug is known to produce locomotor activation through stimulation of postsynaptic D 2 R in NAcc (Breese et al, 1987; Kling-Petersen et al, 1995) , with no significant contribution of D 3 R (Marcellino et al,   2008b ). The enhanced locomotor-activating effect of quinpirole thus indicated that THC treatment may also increase the affinity of agonist binding to D 2 R or their coupling to G-protein, in a manner similar to the effects recently seen with cocaine (Ferraro et al, 2012; Marcellino et al, 2010 (Wilson et al, 2005) and might be confounded by low levels of endogenous DA. However, given that [ 3 H]-( + )-PHNO binding elevation in NAcc is associated with increased mRNA D 3 R levels and with a behavioral sensitization to a postsynaptic dose of quinpirole, it is likely that this effect reflects, at least in part, a supersensitization of D 2/3 R. Thus, in addition to providing convergent evidence to support a THC-induced sensitization of the D 2 R, our study indicates that D 3 R upregulate in NAcc in response to repeated THC in a manner similar to other drugs of abuse (Le Foll et al, 2002 , 2003 Staley and Mash, 1996) . Those results concur to indicate a postsynaptic hyperdopaminergic state following chronic THC.
The mechanism by which THC induces supersensitization of postsynaptic D 2 R remains to be clarified. Besides a compensatory increase in D 2 R resulting from a presynaptic DA deficiency, a molecular mechanism involving modulation of D 2 R signaling by desensitized CB 1 R could be invoked. Indeed, CB 1 R undergo downregulation and functional desensitization during ongoing treatment with THC (review in Sim-Selley, 2003) . These adaptations, which have been consistently demonstrated in CPu but inconsistently in other regions including the NAcc, pallidum, and ventral midbrain (Breivogel et al, 1999; Rodriguez de Fonseca et al, 1994; Romero et al, 1998) , are believed to contribute to behavioral tolerance to the drug. Most studies investigating the effects of chronic THC on CB 1 R have used relatively high doses (ie, typically 10 mg/kg/day and up), and the efficacy of low dose of THC has been questioned based on the dose-dependent effect of cannabinoids on CB 1 R adaptation (McKinney et al, 2008; Sim-Selley, 2003) . Here, we show that chronic THC doses as low as 1 mg/kg/day indeed induce downregulation of CB 1 R mRNA in CPu and ventral midbrain, a result that together with the development of tolerance to the acute hypomotility effect of the drug concurs to indicate a desensitization of CB 1 R. Compelling evidence suggest that such a CB 1 R desensitization may affect D 2 R signaling. Indeed, CB 1 R and D 2 R, which colocalized in dendritic spines of the medium spiny neurons of the striatum (Fitzgerald et al, 2012; Pickel et al, 2006) , interact in an antagonistic and reciprocal manner and form CB 1 R/D 2 R heteromeric complexes in the brain (Kearn et al, 2005) . One consequence of CB 1 R/D 2 R heteromerization is a decreased affinity of D 2 R agonist binding sites in striatum upon CB 1 R stimulation (Marcellino et al, 2008a) , a finding providing a potential mechanism for the well-known inhibitory effect of acute cannabinoid dosing on D 2 R-mediated behaviors (Beltramo et al, 2000; Giuffrida et al, 1999) . In addition to modulating D 2 R agonist affinity, accumulating evidence indicate that CB 1 R may also modulate the membrane expression of D 2 R and vice versa. For instance, chronic D 2 R blockade upregulate striatal levels of CB 1 R (Mailleux and Vanderhaeghen, 1993) . Moreover, mice lacking CB 1 R show increased densities of striatal D 2 R (Houchi et al, 2005) , whereas mice lacking D 2 R show an upregulation of CB 1 R in basal ganglia (Thanos et al, 2011) , indicating that CB 1 R and D 2 R may exert a reciprocal inhibition of their cell-surface expression. Taken together, these observations support the hypothesis that, subsequent to persistent CB 1 R activation by chronic THC, CB 1 R desensitization may alleviate a tonic inhibitory action of CB 1 R onto D 2 R agonist affinity and cell-surface expression, leading to a postsynaptic D 2 R supersensitivity. This hypothesis remains speculative and warrants further investigation. Nevertheless, alterations in D 2/3 R signaling during acute THC cessation may represent early neuroadaptative changes and be a recurrent aspect of intermittent THC exposure that may contribute significantly to the development of addiction. In view of the role of mesolimbic DA in attributing incentive salience to reward-related stimuli (Robinson and Berridge, 2008) , a supersensitivity of D 2 R in NAcc may counteract a diminished presynaptic DA function and serve as the molecular substrate for the acquisition of drug-seeking behavior during the early phase of THC cessation.
Besides its addictive potential, cannabis is increasingly recognized as a drug that may precipitate or exacerbate psychosis in vulnerable individuals (Arseneault et al, 2004) . In patients with schizophrenia, its use is associated with an earlier onset of psychotic illness (Large et al, 2011) , more severe and frequent psychotic episodes (Johns, 2001) , and accumulating evidence suggests that cannabis may be a risk factor for psychosis in predisposed individuals (Moore et al, 2007) . The mechanism by which cannabis can induce psychosis is not known but recent data indicate that D 2 R mechanisms may well have a role in mediating the psychotomimetic effect of THC as this effect is reduced by clinically relevant dose of haloperidol (Liem-Moolenaar et al, 2010) . Moreover, there are several reports suggesting that blocking D 2 R with antipsychotic drugs, particularly second-generation drugs, may improve cannabis use disorder (Green et al, 2003; van Nimwegen et al, 2008) . Considering that a mesolimbic hyperdopaminergic function has been proposed as a possible cause of psychosis (Davis et al, 1991) , a THC-induced supersensitivity of striatal D 2 R may offer a neurochemical basis to better understand how cannabis could potentially contribute to the development of psychosis in predisposed individuals.
In conclusion, the present study indicates that repeated exposure to THC, even at relatively low doses, leads to a neurochemical and functional supersensitivity of D 2/3 R that affect DA neurons in the midbrain and extend to their terminal fields in the dorsal and ventral portions of the striatum. These findings extend the accumulating evidence on cannabinoid modulation of D 2/3 R signaling and suggest that a presynaptic DA hypofunction conjoined with a postsynaptic DA hyperfunction in the nigrostriatal and mesolimbic circuitry may contribute to the mechanism of cannabis addiction.
